Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$83.5 - $98.47 $1.45 Million - $1.71 Million
-17,376 Closed
0 $0
Q4 2020

Jan 15, 2021

SELL
$78.07 - $94.43 $15,067 - $18,224
-193 Reduced 1.1%
17,376 $1.64 Million
Q3 2020

Oct 15, 2020

SELL
$82.14 - $91.0 $224,817 - $249,067
-2,737 Reduced 13.48%
17,569 $1.53 Million
Q2 2020

Jul 09, 2020

SELL
$80.93 - $91.1 $172,219 - $193,860
-2,128 Reduced 9.49%
20,306 $1.77 Million
Q1 2020

Apr 16, 2020

BUY
$70.67 - $99.01 $15,052 - $21,089
213 Added 0.96%
22,434 $1.85 Million
Q4 2019

Jan 17, 2020

SELL
$84.35 - $95.37 $289,573 - $327,405
-3,433 Reduced 13.38%
22,221 $2.1 Million
Q3 2019

Oct 09, 2019

SELL
$85.54 - $94.26 $4,875 - $5,372
-57 Reduced 0.22%
25,654 $2.23 Million
Q2 2019

Jul 23, 2019

BUY
$75.4 - $92.8 $1.94 Million - $2.39 Million
25,711 New
25,711 $2.35 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Arden Trust CO Portfolio

Follow Arden Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.